Discovery of coumarin derivatives as potent and selective cyclin-dependent kinase 9 (CDK9) inhibitors with high antitumour activity.
Xu J, Li H, Wang X, Huang J, Li S, Liu C, Dong R, Zhu G, Duan C, Jiang F, Zhang Y, Zhu Y, Zhang T, Chen Y, Tang W, Lu T.
Xu J, et al. Among authors: zhu g, zhu y.
Eur J Med Chem. 2020 Aug 15;200:112424. doi: 10.1016/j.ejmech.2020.112424. Epub 2020 May 15.
Eur J Med Chem. 2020.
PMID: 32447197